Poland· PL-100344570
Zentel
A albendazole product containing albendazolum, registered in Poland by Delfarma Sp. z o.o.. The same ATC class is registered in 10 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Albendazole is registered in 10 of 19 countries.
Countries holding a registration under ATC P02CA03 (albendazole), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 6 of them publish a price we can compare per daily dose
Albendazole · ATC P02CA03
10 / 19 countries
- Czechiaprice
- Franceprice
- Germany
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of albendazole costs, country by country.
Normalised to the WHO defined daily dose (0.8 g), the median price runs from $5.63 in France to $36.54 in Switzerland — a ×6.5 gap.
- 2 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Albendazole · price per daily dose (0.8 g)
USD · FX 28 Sept 2026
- CH Switzerland$36.54
- FR France$5.63
The record
At a glance
URPL (Poland)- Active substance
- Albendazolum
- Manufacturer
- Delfarma Sp. z o.o.
- Country
- Poland (PL)
- ATC code
- P02CA03
- ATC class
- Albendazole
- Defined daily dose
- 0.8 g, O
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 1
- gtin05909991223250
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
114 interactions on record for albendazole.
Graded by severity as the source publishes them — 3 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Albendazole · interactions on record
114 records
- 3 severe
- 102 moderate
- 9 minor
Most severe, free to view
- CladribineL01BB04severe
- CladribineL04AA40severe
- ClozapineN05AH02severe
- AprepitantA04AD12moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Albendazole in 12 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomAlbendazole 400mg chewable tabletsSpecial Order
- NorwayAlbendazol micro labsMicro Labs
- SwitzerlandZentel, KautablettenGlaxoSmithKline AG
- United StatesAlbendazoleAlembic Pharmaceuticals Inc.
- NetherlandsEskazole 400 mg tablettenBModesto B.V.
- FranceESKAZOLE 400 mg, compriméGLAXOSMITHKLINE
- GermanyAlbendazol Micro LabsMicro Labs Gmbh
- CanadaVALBAZENZOETIS CANADA INC
Authorised across Europe · EMA
The same active substance is authorised in 16 EEA countries. Names it is sold under:
- Austria · Eskazole
- Bulgaria · Зентел
- Cyprus · Zestaval
- Germany · Albendazol Micro Labs, Eskazole
- Spain · Eskazole
- France · Eskazole, Zentel
- United Kingdom (Northern Ireland) · Albendazole Brown & Burk Uk
- Greece · Albendol
- Hungary · Albendazol Pharma Vim
- Italy · Zentel
- Luxembourg · Albendazol Micro Labs
- Malta · Zestaval
- Netherlands · Eskazole
- Portugal · Zentel
- Romania · Albendazol Vim Spectrum, Duador
- Slovakia · Zentel
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/cf96e83c-fae0-46e9-a926-99744190d2fb GET /v1/drugs/cf96e83c-fae0-46e9-a926-99744190d2fb?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tabletki do rozgryzania i żucia",
"source": "urpl",
"strength": "400 mg",
"packaging": "05909991223250 ¦ Rp ¦ 108559\n1 tabl.",
"substance": "Albendazolum 400 mg",
"common_name": "Albendazolum",
"pl_product_id": "100344570",
"pozwolenie_nr": "260/15",
"auth_procedure": "IR",
"authorisation_validity": "2030-05-25"
}See everything about albendazole.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.